Nectin-4 drives aggressive tumor biology and poor prognosis in renal cell carcinoma.

Hatayama T, Sekino Y, Babasaki T, Sentani K, Nakahara H, Shikuma H, Iwane K, Yukihiro K, Kohada Y, Naito M, Miyamoto S, Kobatake K, Kitano H, Goto K, Hieda K, Hinoi T, Hinata N.

Open source

DOI: 10.1016/j.urolonc.2026.05.012
Published: 2026-06-05
Container: Urol Oncol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.urolonc.2026.05.012,
  title = {Nectin-4 drives aggressive tumor biology and poor prognosis in renal cell carcinoma.},
  author = {Hatayama T and  Sekino Y and  Babasaki T and  Sentani K and  Nakahara H and  Shikuma H and  Iwane K and  Yukihiro K and  Kohada Y and  Naito M and  Miyamoto S and  Kobatake K and  Kitano H and  Goto K and  Hieda K and  Hinoi T and  Hinata N.},
  year = {2026},
  journal = {Urol Oncol},
  doi = {10.1016/j.urolonc.2026.05.012},
  url = {https://doi.org/10.1016/j.urolonc.2026.05.012}
}

RIS

TY  - JOUR
TI  - Nectin-4 drives aggressive tumor biology and poor prognosis in renal cell carcinoma.
AU  - Hatayama T
AU  -  Sekino Y
AU  -  Babasaki T
AU  -  Sentani K
AU  -  Nakahara H
AU  -  Shikuma H
AU  -  Iwane K
AU  -  Yukihiro K
AU  -  Kohada Y
AU  -  Naito M
AU  -  Miyamoto S
AU  -  Kobatake K
AU  -  Kitano H
AU  -  Goto K
AU  -  Hieda K
AU  -  Hinoi T
AU  -  Hinata N.
PY  - 2026
JO  - Urol Oncol
DO  - 10.1016/j.urolonc.2026.05.012
UR  - https://doi.org/10.1016/j.urolonc.2026.05.012
ER  -

APA

T, H., Y, S., T, B., K, S., H, N., H, S., K, I., K, Y., Y, K., M, N., S, M., K, K., H, K., K, G., K, H., T, H., & N., H. (2026). Nectin-4 drives aggressive tumor biology and poor prognosis in renal cell carcinoma.. Urol Oncol. https://doi.org/10.1016/j.urolonc.2026.05.012

Source records

europe-pmc · retrieved 2026-09-26T10:10:29.103Z